Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
<a href="https://www.fiercebiotech.com/biotech/jjs-5b-alzheimers-hope-fades-anti-tau-antibody-posdinemab-flops-phase-2" hreflang="en">J&J's $5B Alzheimer's hope fades as anti-tau antibody posdinemab flops in phase 2</a>
Johnson & Johnson’s attempt to develop a $5 billion-a-year Alzheimer’s disease drug has been rocked by a phase 2 flop. A scheduled data review found the anti-tau antibo...
<a href="https://www.fiercebiotech.com/pharma/novos-shares-tumble-8-after-2-trial-misses-semaglutide-alzheimers-disease" hreflang="en">Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease</a>
Novo Nordisk has come up short in two phase 3 trials of semaglutide as a treatment for Alzheimer’s disease. But perhaps the larger story associated with the unsurprisin...
J&J’s tau-targeting antibody fails Phase 2 Alzheimer's study
Johnson & Johnson’s anti-tau monoclonal antibody failed to slow the progression of Alzheimer’s in patients with early-stage disease, marking the end of one of the compa...
Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials
Novo Nordisk’s bet on semaglutide in Alzheimer’s disease was always a long shot, and like most long shots, it has missed the mark. The GLP-1 agonist failed to delay dis...
Novo’s semaglutide fails in phase III Alzheimer’s trials
Novo Nordisk A/S’ wild card bet that its GLP-1 receptor agonist semaglutide could be used to treat Alzheimer’s disease has not paid off, with the company reporting two...
Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies
The studies offer perhaps the most concrete rebuttal yet to an idea that GLP-1 drugs, which have profound benefits on weight loss and heart health, might also help comb...
Novo’s semaglutide fails in phase III Alzheimer’s trials
Novo Nordisk A/S’ wild card bet that its GLP-1 receptor agonist semaglutide could be used to treat Alzheimer’s disease has not paid off, with the company reporting two...
APOE4 and CRISPR are reframing Alzheimer’s Risk
SPONSORED APOE4 and CRISPR are reframing Alzheimer’s Risk Published Nov. 24, 2025 Getty Images Sponsored content By Pearson Groundbreaking research has led to new diagn...
The next leap in Alzheimer’s R&D is coming, but not around the corner
While a couple drugs have reached the market, their effects are still modest, and experts say a true paradigm shift is still a ways off.
Roche nabs FDA clearance for Alzheimer's biomarker blood test - Fierce Biotech
Roche nabs FDA clearance for Alzheimer's biomarker blood test Fierce Biotech
FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related Amyloid Pathology - NeurologyLive
FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related Amyloid Pathology NeurologyLive
Roche, Lilly's blood test for Alzheimer's diagnosis gets US approval - Reuters
Roche, Lilly's blood test for Alzheimer's diagnosis gets US approval Reuters
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page Thermo Fisher Core Tools & Instruments
Track Danaher Core Tools & Instruments
Track Agilent Core Tools & Instruments
Track Merck KGaA Core Tools & Instruments
Track Illumina Core Tools & Instruments
Track Waters Core Tools & Instruments
Track Bruker Core Tools & Instruments
Track Sartorius Core Tools & Instruments
Track Mettler Toledo Core Tools & Instruments
Track PerkinElmer (Revvity) Core Tools & Instruments
Track Bio-Rad Core Tools & Instruments
Track Carl Zeiss Core Tools & Instruments
Track Leica Microsystems Core Tools & Instruments
Track Nikon Core Tools & Instruments
Track Eppendorf Core Tools & Instruments
Track Corning Core Tools & Instruments
Track BD (Becton Dickinson) Core Tools & Instruments
Track Beckman Coulter Core Tools & Instruments
Track Qiagen Core Tools & Instruments
Track Abcam Core Tools & Instruments
Track MGI Tech (华大智造) Core Tools & Instruments
Track Haier Biomedical Core Tools & Instruments
Track Lonza Outsourcing Services (CRO / CDMO)
Track WuXi AppTec (药明康德) Outsourcing Services (CRO / CDMO)
Track WuXi Biologics Outsourcing Services (CRO / CDMO)
Track Charles River Outsourcing Services (CRO / CDMO)
Track Catalent Outsourcing Services (CRO / CDMO)
Track Samsung Biologics Outsourcing Services (CRO / CDMO)
Track IQVIA Outsourcing Services (CRO / CDMO)
Track LabCorp Outsourcing Services (CRO / CDMO)
Track Eurofins Outsourcing Services (CRO / CDMO)
Track Pharmaron (康龙化成) Outsourcing Services (CRO / CDMO)
Track Pfizer Pharma, Biotech & AI
Track Roche Pharma, Biotech & AI
Track Merck & Co. (MSD) Pharma, Biotech & AI
Track Novartis Pharma, Biotech & AI
Track Eli Lilly Pharma, Biotech & AI
Track Novo Nordisk Pharma, Biotech & AI
Track Moderna Pharma, Biotech & AI
Track BioNTech Pharma, Biotech & AI
Track Amgen Pharma, Biotech & AI
Track BeiGene (百济神州) Pharma, Biotech & AI
Track Vertex Pharma, Biotech & AI
Track Schrödinger Pharma, Biotech & AI
Track Recursion Pharma, Biotech & AI
Track Exscientia Pharma, Biotech & AI
Track Insilico Medicine Pharma, Biotech & AI
Track XtalPi (晶泰科技) Pharma, Biotech & AI
Track NVIDIA Healthcare Pharma, Biotech & AI
Track DeepMind (Google) Pharma, Biotech & AI
Track Medtronic MedTech & Diagnostics
Track Siemens Healthineers MedTech & Diagnostics
Track GE HealthCare MedTech & Diagnostics
Track Philips MedTech & Diagnostics
Track Abbott MedTech & Diagnostics
Track Intuitive Surgical MedTech & Diagnostics
Track Boston Scientific MedTech & Diagnostics
Track Edwards Lifesciences MedTech & Diagnostics
Track Mindray (迈瑞) MedTech & Diagnostics
Track United Imaging (联影) MedTech & Diagnostics
Track Sysmex MedTech & Diagnostics
Track Hologic MedTech & Diagnostics
Track